NTL Healthcare, a company specialized in women's cancer, has announced the successful development of

a women's feminine cleanser containing NK cell culture extract in collaboration with a company specialized

in immune cell therapy, Immune's Bio.

 

 

NK cells are innate immune cells that eliminate viruses, bacteria, and cancer cells. They are often referred to

as "natural killer cells" because they selectively target and eliminate infected and abnormal cells.

As is well known, NK cells are essential for maintaining immunity against thousands of abnormal cells

that arise from various harmful environments such as stress, smoking, irregular lifestyle habits, and new viruses.

When the activity of NK cells is diminished, the likelihood of infection from viruses and vaginal inflammation increases.

Therefore, it is important to activate NK cells, which are a part of the immune system.

 

 

In collaboration with NTL, Immune's Bio, a company specialized in immune cell therapy, has successfully developed

a safe NK cell culture extract and achieved the inclusion of it in the international cosmetic ingredient list.

They are now supplying "NK cell culture extract" contained in 'Iner:y NK’.

 

 

An official from Immune's Bio stated, "The NK immune cell therapy product, cultured using our proprietary technology,

has already been commercialized as a cancer treatment overseas. Currently, commercial clinical trials

for breast cancer, stomach cancer, and other types of cancer are underway in numerous university hospitals in Korea."

 

 

An official from NTL stated, "With the release of the women's feminine cleanser 'Iner:y NK,' we aim to solidify our position

as a leading women’s cancer specialized company. Also, we plan to lead the global market through

the development of cervical cancer treatments in collaboration with Immune's Bio.